Effect of Unani drugs on Dandruff
Phase 2
- Conditions
- Health Condition 1: L218- Other seborrheic dermatitis
- Registration Number
- CTRI/2022/04/041692
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of either sex in the age group between 18 to 50 years
Patients with Adherent Scalp Flaking Score upto grade 3 i.e, thick heaped-up scales but not forming plaque
Patients with positive woodâ??s lamp finding i.e. fluorescence (bluish white)
Exclusion Criteria
Patients below 18 and above 50 years of age.
Patients who underwent local procedures within the past 2 weeks or during the study.
Patients with history of disease such as HIV, Parkinsonâ??s disease, viral or fungal infections.
Pregnant or lactating females.
Patients with other concomitant skin diseases like dermatoses, psoriasis, eczema and atopic dermatitis.
Patients using other topical medications including medicated shampoos/oils or antibiotics during course of trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reversal of ASFS (Adherent scalp flaking score). <br/ ><br>Negative Woodâ??s lamp findings. <br/ ><br>Timepoint: 21 days
- Secondary Outcome Measures
Name Time Method Improvement in Quality Of Life (Scalpdex)Timepoint: 21 days